Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

399
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
399
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

510
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
510
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

382
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
382
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

438
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
438
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

576
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
576
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

408
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
408

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment patterns for patients with initial diagnosis of smoldering multiple myeloma in the United States: a SEER-Medicare analysis.

Haematologica·2026
Same author

Potential Benefits and Harms of Screening Strategies for Monoclonal Gammopathy of Undetermined Significance in the US: A Simulation Study.

Clinical lymphoma, myeloma & leukemia·2026
Same author

Incidence of depression in patients with psoriasis and psoriatic arthritis treated with biologic therapy: Protocol for a systematic review and meta-analysis.

PloS one·2026
Same author

Magnetic Properties of Ge-Doped Fe<sub>3</sub>GaTe<sub>2</sub> van der Waals Ferromagnets.

The journal of physical chemistry letters·2026
Same author

Functional Divergence of the PAL Gene Family in Salt and Cadmium Stress Responses of Populus alba.

Physiologia plantarum·2026
Same author

Ultrafast Demagnetization Dynamics in Room-Temperature vdW Ferromagnet Fe<sub>3</sub>GaTe<sub>2</sub>.

The journal of physical chemistry letters·2026

Related Experiment Video

Updated: Feb 24, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.7K

Cost-Effectiveness of Multidisciplinary Management Program and Exercise Training Program in Heart Failure.

Weixiong Dang1, Anji Yi1, Sunny Jhamnani2

  • 1Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut.

The American Journal of Cardiology
|August 27, 2017
PubMed
Summary

A multidisciplinary management program (MMP) is cost-effective for heart failure patients, offering more life years than usual care. Exercise training programs (ETP) are not cost-effective compared to MMP from a societal view.

More Related Videos

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.6K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K

Related Experiment Videos

Last Updated: Feb 24, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.7K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.6K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K

Area of Science:

  • Cardiovascular Medicine
  • Health Economics
  • Public Health

Background:

  • Heart failure presents substantial health and financial burdens.
  • Multidisciplinary management programs (MMP) and exercise training programs (ETP) show promise in improving outcomes.
  • Comparative cost-effectiveness of MMP and ETP has not been previously studied.

Purpose of the Study:

  • To compare the cost-effectiveness of usual care (UC), MMP, and ETP for heart failure management.
  • To evaluate life years (LY) gained and total costs associated with each management strategy.
  • To determine the incremental cost-effectiveness ratio (ICER) for MMP versus UC and ETP versus MMP.

Main Methods:

  • A Markov model was developed to simulate patient outcomes over a 10-year horizon.
  • Transition probabilities and healthcare costs were derived from existing literature.
  • One-way and probabilistic sensitivity analyses were performed to assess model robustness.

Main Results:

  • Expected LY gained: UC (7.6), MMP (8.2), ETP (8.4).
  • Societal costs: UC ($20,092), MMP ($20,695), ETP ($48,378).
  • ICER: MMP vs. UC ($976/LY gained); ETP vs. MMP ($165,702/LY gained).

Conclusions:

  • MMP is a cost-effective strategy compared to UC for heart failure management.
  • ETP is not cost-effective compared to MMP from a societal perspective.
  • ETP may be cost-effective from a healthcare payer's viewpoint.